These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28676312)

  • 1. Multiple sclerosis: Frequency, cost, and economic burden in the United States.
    Chen AY; Chonghasawat AO; Leadholm KL
    J Clin Neurosci; 2017 Nov; 45():180-186. PubMed ID: 28676312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost of multiple sclerosis in France].
    Fromont A; Lehanneur MN; Rollot F; Weill A; Clerc L; Bonithon Kopp C; Binquet C; Moreau T
    Rev Neurol (Paris); 2014; 170(6-7):432-9. PubMed ID: 24856285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
    Rotstein Z; Hazan R; Barak Y; Achiron A
    Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts.
    Amankwah N; Marrie RA; Bancej C; Garner R; Manuel DG; Wall R; Finès P; Bernier J; Tu K; Reimer K
    Health Promot Chronic Dis Prev Can; 2017 Feb; 37(2):37-48. PubMed ID: 28273039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital admission rates for pediatric multiple sclerosis in the United States using the Pediatric Health Information System (PHIS).
    Lavery AM; Banwell BL; Liu G; Waldman AT
    Mult Scler Relat Disord; 2016 Sep; 9():5-10. PubMed ID: 27645335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015.
    Earla JR; Thornton JD; Hutton GJ; Aparasu RR
    J Manag Care Spec Pharm; 2020 Jun; 26(6):741-749. PubMed ID: 32463779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database.
    Prescott JD; Factor S; Pill M; Levi GW
    J Manag Care Pharm; 2007; 13(1):44-52. PubMed ID: 17269836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Trends in Direct Health Care Expenditures Among US Adults With Migraine: 2004 to 2013.
    Raval AD; Shah A
    J Pain; 2017 Jan; 18(1):96-107. PubMed ID: 27789258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs--pharmacy and medical benefit spending from 2004 through 2007.
    Kunze AM; Gunderson BW; Gleason PP; Heaton AH; Johnson SV
    J Manag Care Pharm; 2007; 13(9):799-806. PubMed ID: 18062731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
    Adelman G; Rane SG; Villa KF
    J Med Econ; 2013; 16(5):639-47. PubMed ID: 23425293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of age and sex on cost of inpatient facility encounters among patients with multiple sclerosis.
    Kozma CM; Meletiche DM; Phillips AL
    J Med Econ; 2015; 18(9):704-10. PubMed ID: 25913916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic trends in hospitalization for multiple sclerosis.
    Lad SP; Chapman CH; Vaninetti M; Steinman L; Green A; Boakye M
    Neuroepidemiology; 2010 Aug; 35(2):93-9. PubMed ID: 20551694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of urgency urinary incontinence in the United States: a systematic review.
    Coyne KS; Wein A; Nicholson S; Kvasz M; Chen CI; Milsom I
    J Manag Care Pharm; 2014 Feb; 20(2):130-40. PubMed ID: 24456314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How much is the cost of multiple sclerosis--systematic literature review.
    Kolasa K
    Przegl Epidemiol; 2013; 67(1):75-9, 157-60. PubMed ID: 23745380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life of multiple sclerosis in the United Kingdom.
    Kobelt G; Berg J; Lindgren P; Kerrigan J; Russell N; Nixon R
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S96-104. PubMed ID: 17310341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct medical costs of hospitalisations for mental disorders in Shanghai, China: a time series study.
    Chen W; Wang S; Wang Q; Wang W
    BMJ Open; 2017 Oct; 7(10):e015652. PubMed ID: 29084785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of Care for Hospitalization for Pemphigus in the United States.
    Hsu D; Brieva J; Silverberg JI
    JAMA Dermatol; 2016 Jun; 152(6):645-54. PubMed ID: 26865293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.